# PRIMA PFO Migraine Trial

> **NCT00505570** · PHASE2 · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 107 (actual)

## Conditions studied

- Migraine
- Migraine With Aura
- Patent Foramen Ovale
- PFO

## Interventions

- **DEVICE:** AMPLATZER® PFO Occluder Device

## Key facts

- **NCT ID:** NCT00505570
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505570, "PRIMA PFO Migraine Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00505570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*